fda approval of tirzepatide for weight loss Breakthrough in Management: Zepbound's New Weight Loss Drug Approved!

Conditions such as hypothyroidism, polycystic ovary syndrome (PCOS), and insulin resistance can all slow down weight loss efforts

Constipation rates are 12-27% depending on dose

Healthcare providers may avoid prescribing Saxenda for people with: A history of pancreatitis Gallbladder problems Heart problems Kidney or liver disease Thyroid disorders (like medullary thyroid carcinomaor MTC) Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) Diabetic ketoacidosis Digestion problems High cholesterol or triglyceride levels Saxenda may not be prescribed to pregnant women, women who are trying to conceive, or women who are breastfeeding

You should contact your health care provider immediately if you suspect that you have a medical problem

The thigh also accommodates shorter needles well

Whether your goals are significant weight loss or weight maintenance, make this clear from the start